Nonthrombocytopenic Purpura Induced by Cefoxitin

Van Winzum C. Clinical safety and tolerance of cefoxitin sodium — An overview. J Antimicrob Chemother 1978; 4 (suppl B): 91–104.

Gurmith M Albritton W Lank B Harding G Ronald A. Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic organisms. In: Siegenthaler W Luthy R , eds. Current chemotherapy—proceedings of the 10th International Congress of Chemotherapy. Vol. 1. Washington, DC: American Society of Microbiology, 1978; 2: 787–8.

Kannagara DW Smith B Cohen K. Exfoliative dermatitis during cefoxitin therapy. Arch Intern Med 1982; 142: 1031–2.

Ribner BS Freimer EH Billiard BS ., Clinical experience with cefoxitin. In: Siegenthaler W Luthy R , eds. Current chemotherapy—proceedings of the 10th International Congress of Chemotherapy. Vol. 1. Washington, DC: American Society of Microbiology, 1978; 2: 778–80.

Haskell RJ Fujita NK Stevenson JA , Cefoxitin induced interstitial nephritis (letter). Arch Intern Med 1981; 141: 1557.

Tall LL Lee M Sharif R. Cefoxitin induced interstitial nephritis. South Med J 1980; 80: 274–5.

Ekenstam E Callen JP ., Cutaneous leukocytoclastic vasculitis. Arch Dermatol 1984; 120: 484–9.